pharma · Anorectal Disorder · Localized Primary Osteoarthritis of Both Hips (Diagnosis)
Chia Tai Tianqing
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
Chia Tai Tianqing is a pharma organization headquartered in CN. Primary therapeutic focus areas include Anorectal Disorder, Localized Primary Osteoarthritis of Both Hips (Diagnosis), Recovery of Bowel Function, Due to Gu
Lianyungang, CN HQ
366 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Lianyungang, CN
- Employees
- 366
- Programs
- 11
- Drugs
- 15
- Patents
- 0
Mevac-A vaccine
Phase 3 · mab · HAV
Mevac-A vaccine for HAV is a Phase 3 program (mab) at Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).
Internal code PED-2566-0634
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
- Phase
- Phase 3
- Modality
- mab
- Indication
- HAV
- Status
- completed
- Trials
- 1